Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortiumLoveleen Bansi‐Matharu, Lene Ryom, Andrew Phillips et al.|The Lancet HIV|2021Cited by 65
Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment–Experienced People Living With Human Immunodeficiency VirusLauren Greenberg, H Appoyer, Lene Ryom et al.|Clinical Infectious Diseases|2020Cited by 22
Trends in asymptomatic STI among HIV-positive MSM and lessons for systematic screeningÉric Farfour, Svetlane Dimi, Olivier Chassany et al.|PLoS ONE|2021Cited by 21
Same-day initiation of bictegravir/emtricitabine/tenofovir alafenamide: Week 48 results of the FAST study—IMEA 055Antoine Bachelard, Fatima Touam, Valentina Isernia et al.|Journal of Antimicrobial Chemotherapy|2023Cited by 14
The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA studyAmanda Mocroft, Claudine Duvivier, Caterina Uberti‐Foppa et al.|HIV Medicine|2021Cited by 3